Background
Coronavirus disease (COVID-19) started in China as a severe pneumonia of
unknown cause in late 2019 and quickly spread throughout the world with
human-to-human transmission. COVID-19 was declared a pandemic in the
first quarter of 2020 by the World Health Organization (WHO) and has
caused a significant loss of human lives and financial resources
worldwide.(1) The pandemic is far from being over and has compromised
even the most developed countries’ healthcare systems. There are various
risk factors for getting severe COVID-19 infection, such as patients’
age, co-morbidities such as diabetes, cardiovascular and chronic
respiratory disorders (2-4). However, the role of immunosuppression
therapy is still not clear.(5) Use of the immunosuppressant medication
in post-renal transplant patients may increase the risk of various viral
infections.(6)
Adequate literature is not available from the region regarding the
impact of COVID-19 infection in post-renal transplant patients, whereas
the international literature is limited to a case series with contrast
findings and conclusions.(7)
This case series explores the occurrence of COVID-19 infection in
post-renal transplant patients, their risk factors, severity, course of
the disease, and outcomes.